nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—CYP2D6—Lomustine—brain cancer	0.106	0.183	CbGbCtD
Almotriptan—CYP1A2—Carmustine—brain cancer	0.105	0.181	CbGbCtD
Almotriptan—CYP2D6—Hydroxyurea—brain cancer	0.0804	0.139	CbGbCtD
Almotriptan—CYP3A4—Temozolomide—brain cancer	0.0794	0.137	CbGbCtD
Almotriptan—CYP3A4—Lomustine—brain cancer	0.0675	0.116	CbGbCtD
Almotriptan—CYP2E1—Etoposide—brain cancer	0.0538	0.0928	CbGbCtD
Almotriptan—CYP2C8—Etoposide—brain cancer	0.0402	0.0693	CbGbCtD
Almotriptan—CYP1A2—Etoposide—brain cancer	0.0311	0.0537	CbGbCtD
Almotriptan—HTR1D—meninx—brain cancer	0.023	0.14	CbGeAlD
Almotriptan—HTR1B—dura mater—brain cancer	0.0219	0.133	CbGeAlD
Almotriptan—HTR1D—dura mater—brain cancer	0.0212	0.129	CbGeAlD
Almotriptan—CYP3A4—Etoposide—brain cancer	0.0163	0.0281	CbGbCtD
Almotriptan—HTR1B—trigeminal nerve—brain cancer	0.00941	0.0573	CbGeAlD
Almotriptan—HTR1D—trigeminal nerve—brain cancer	0.00911	0.0555	CbGeAlD
Almotriptan—HTR1B—cranial nerve—brain cancer	0.0067	0.0409	CbGeAlD
Almotriptan—HTR1D—cranial nerve—brain cancer	0.00649	0.0396	CbGeAlD
Almotriptan—HTR1B—telencephalic ventricle—brain cancer	0.00545	0.0332	CbGeAlD
Almotriptan—HTR1D—telencephalic ventricle—brain cancer	0.00528	0.0322	CbGeAlD
Almotriptan—HTR1B—ganglion—brain cancer	0.00339	0.0207	CbGeAlD
Almotriptan—HTR1D—ganglion—brain cancer	0.00329	0.02	CbGeAlD
Almotriptan—HTR1B—blood vessel—brain cancer	0.0027	0.0164	CbGeAlD
Almotriptan—HTR1D—blood vessel—brain cancer	0.00261	0.0159	CbGeAlD
Almotriptan—CYP2C8—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00253	0.0319	CbGpPWpGaD
Almotriptan—MAOA—ganglion—brain cancer	0.0025	0.0152	CbGeAlD
Almotriptan—CYP2E1—CYP2E1 reactions—CYP2C9—brain cancer	0.00249	0.0314	CbGpPWpGaD
Almotriptan—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00248	0.0313	CbGpPWpGaD
Almotriptan—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00226	0.0285	CbGpPWpGaD
Almotriptan—CYP2C8—CYP2E1 reactions—CYP2C9—brain cancer	0.00215	0.0272	CbGpPWpGaD
Almotriptan—Nightmare—Procarbazine—brain cancer	0.00199	0.0115	CcSEcCtD
Almotriptan—Neuropathy—Procarbazine—brain cancer	0.00194	0.0112	CcSEcCtD
Almotriptan—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00193	0.0244	CbGpPWpGaD
Almotriptan—Parosmia—Temozolomide—brain cancer	0.00192	0.0111	CcSEcCtD
Almotriptan—CYP2C19—CYP2E1 reactions—CYP2C9—brain cancer	0.00192	0.0242	CbGpPWpGaD
Almotriptan—MAOA—hindbrain—brain cancer	0.0019	0.0116	CbGeAlD
Almotriptan—FMO3—pituitary gland—brain cancer	0.00182	0.0111	CbGeAlD
Almotriptan—Myopathy—Temozolomide—brain cancer	0.00178	0.0103	CcSEcCtD
Almotriptan—FMO3—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00177	0.0224	CbGpPWpGaD
Almotriptan—CYP2D6—CYP2E1 reactions—CYP2C9—brain cancer	0.00177	0.0223	CbGpPWpGaD
Almotriptan—Eletriptan—CYP2C9—brain cancer	0.00176	0.536	CrCbGaD
Almotriptan—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00176	0.0222	CbGpPWpGaD
Almotriptan—Scotoma—Carmustine—brain cancer	0.0017	0.0098	CcSEcCtD
Almotriptan—Scotoma—Temozolomide—brain cancer	0.00164	0.00947	CcSEcCtD
Almotriptan—Otitis media—Temozolomide—brain cancer	0.0016	0.00924	CcSEcCtD
Almotriptan—Visual impairment—Lomustine—brain cancer	0.00157	0.00907	CcSEcCtD
Almotriptan—CYP2E1—Xenobiotics—CYP2C9—brain cancer	0.00154	0.0195	CbGpPWpGaD
Almotriptan—Melatonin—CYP2C9—brain cancer	0.00152	0.464	CrCbGaD
Almotriptan—Diplopia—Procarbazine—brain cancer	0.0015	0.00864	CcSEcCtD
Almotriptan—CYP2E1—Tamoxifen metabolism—CYP2C9—brain cancer	0.00148	0.0187	CbGpPWpGaD
Almotriptan—HTR1B—brainstem—brain cancer	0.00148	0.00899	CbGeAlD
Almotriptan—Disturbance in attention—Temozolomide—brain cancer	0.00144	0.0083	CcSEcCtD
Almotriptan—Breast pain—Temozolomide—brain cancer	0.00143	0.00824	CcSEcCtD
Almotriptan—HTR1D—brainstem—brain cancer	0.00143	0.0087	CbGeAlD
Almotriptan—FMO3—endocrine gland—brain cancer	0.00141	0.00857	CbGeAlD
Almotriptan—FMO3—head—brain cancer	0.00139	0.00847	CbGeAlD
Almotriptan—Laryngospasm—Etoposide—brain cancer	0.00134	0.00771	CcSEcCtD
Almotriptan—CYP2C8—Xenobiotics—CYP2C9—brain cancer	0.00133	0.0168	CbGpPWpGaD
Almotriptan—Coordination abnormal—Carmustine—brain cancer	0.00132	0.00758	CcSEcCtD
Almotriptan—HTR1B—telencephalon—brain cancer	0.00131	0.00798	CbGeAlD
Almotriptan—Neck pain—Carmustine—brain cancer	0.00131	0.00753	CcSEcCtD
Almotriptan—CYP2C8—Tamoxifen metabolism—CYP2C9—brain cancer	0.00128	0.0162	CbGpPWpGaD
Almotriptan—Coordination abnormal—Temozolomide—brain cancer	0.00127	0.00733	CcSEcCtD
Almotriptan—FMO3—central nervous system—brain cancer	0.00127	0.00773	CbGeAlD
Almotriptan—HTR1D—telencephalon—brain cancer	0.00127	0.00772	CbGeAlD
Almotriptan—Sweating increased—Procarbazine—brain cancer	0.00126	0.00727	CcSEcCtD
Almotriptan—Angina pectoris—Procarbazine—brain cancer	0.00126	0.00727	CcSEcCtD
Almotriptan—Neuropathy—Carmustine—brain cancer	0.00121	0.00699	CcSEcCtD
Almotriptan—CYP2C19—Xenobiotics—CYP2C9—brain cancer	0.00119	0.015	CbGpPWpGaD
Almotriptan—Photosensitivity reaction—Procarbazine—brain cancer	0.00118	0.00681	CcSEcCtD
Almotriptan—Neuropathy—Temozolomide—brain cancer	0.00117	0.00675	CcSEcCtD
Almotriptan—Dry eye—Temozolomide—brain cancer	0.00115	0.00664	CcSEcCtD
Almotriptan—CYP2C19—Tamoxifen metabolism—CYP2C9—brain cancer	0.00115	0.0145	CbGpPWpGaD
Almotriptan—Pain—Carboplatin—brain cancer	0.00113	0.00654	CcSEcCtD
Almotriptan—Neuropathy peripheral—Procarbazine—brain cancer	0.00113	0.00652	CcSEcCtD
Almotriptan—CYP2D6—hindbrain—brain cancer	0.00113	0.00687	CbGeAlD
Almotriptan—Mental disability—Carmustine—brain cancer	0.00112	0.00646	CcSEcCtD
Almotriptan—FMO3—SIDS Susceptibility Pathways—HES5—brain cancer	0.00111	0.014	CbGpPWpGaD
Almotriptan—CYP2D6—Xenobiotics—CYP2C9—brain cancer	0.0011	0.0138	CbGpPWpGaD
Almotriptan—Epistaxis—Procarbazine—brain cancer	0.00109	0.00628	CcSEcCtD
Almotriptan—MAOA—brainstem—brain cancer	0.00109	0.00663	CbGeAlD
Almotriptan—Mental disability—Temozolomide—brain cancer	0.00108	0.00624	CcSEcCtD
Almotriptan—Ear pain—Temozolomide—brain cancer	0.00106	0.00612	CcSEcCtD
Almotriptan—CYP2D6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00105	0.0133	CbGpPWpGaD
Almotriptan—Body temperature increased—Carboplatin—brain cancer	0.00105	0.00604	CcSEcCtD
Almotriptan—Breast disorder—Hydroxyurea—brain cancer	0.00105	0.00604	CcSEcCtD
Almotriptan—Eye pain—Carmustine—brain cancer	0.00104	0.00599	CcSEcCtD
Almotriptan—Gastroenteritis—Temozolomide—brain cancer	0.00102	0.00589	CcSEcCtD
Almotriptan—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.00101	0.0127	CbGpPWpGaD
Almotriptan—FMO3—brain—brain cancer	0.00101	0.00613	CbGeAlD
Almotriptan—Eye pain—Temozolomide—brain cancer	0.001	0.00578	CcSEcCtD
Almotriptan—MAOA—telencephalon—brain cancer	0.000965	0.00588	CbGeAlD
Almotriptan—Thirst—Temozolomide—brain cancer	0.000952	0.00549	CcSEcCtD
Almotriptan—FMO3—Biological oxidations—CYP2C9—brain cancer	0.000941	0.0119	CbGpPWpGaD
Almotriptan—HTR1B—midbrain—brain cancer	0.00094	0.00573	CbGeAlD
Almotriptan—Neuropathy—Etoposide—brain cancer	0.000938	0.0054	CcSEcCtD
Almotriptan—Diplopia—Carmustine—brain cancer	0.000938	0.0054	CcSEcCtD
Almotriptan—Chills—Procarbazine—brain cancer	0.00093	0.00536	CcSEcCtD
Almotriptan—FMO3—Metapathway biotransformation—CYP2C9—brain cancer	0.000928	0.0117	CbGpPWpGaD
Almotriptan—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.000928	0.0117	CbGpPWpGaD
Almotriptan—HTR1B—spinal cord—brain cancer	0.000917	0.00559	CbGeAlD
Almotriptan—Body temperature increased—Lomustine—brain cancer	0.000917	0.00529	CcSEcCtD
Almotriptan—HTR1D—midbrain—brain cancer	0.00091	0.00555	CbGeAlD
Almotriptan—Diplopia—Temozolomide—brain cancer	0.000906	0.00522	CcSEcCtD
Almotriptan—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.000892	0.0113	CbGpPWpGaD
Almotriptan—Tension—Procarbazine—brain cancer	0.000886	0.0051	CcSEcCtD
Almotriptan—Nervousness—Procarbazine—brain cancer	0.000877	0.00505	CcSEcCtD
Almotriptan—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000876	0.00505	CcSEcCtD
Almotriptan—MAOA—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000847	0.0107	CbGpPWpGaD
Almotriptan—Tremor—Procarbazine—brain cancer	0.000846	0.00487	CcSEcCtD
Almotriptan—Muscular weakness—Carmustine—brain cancer	0.000827	0.00477	CcSEcCtD
Almotriptan—HTR1B—endocrine gland—brain cancer	0.000826	0.00503	CbGeAlD
Almotriptan—Breast disorder—Temozolomide—brain cancer	0.000819	0.00472	CcSEcCtD
Almotriptan—CYP2C19—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000818	0.0103	CbGpPWpGaD
Almotriptan—HTR1B—head—brain cancer	0.000815	0.00497	CbGeAlD
Almotriptan—Syncope—Procarbazine—brain cancer	0.000809	0.00466	CcSEcCtD
Almotriptan—Muscular weakness—Temozolomide—brain cancer	0.000799	0.00461	CcSEcCtD
Almotriptan—Loss of consciousness—Procarbazine—brain cancer	0.000793	0.00457	CcSEcCtD
Almotriptan—HTR1D—head—brain cancer	0.000789	0.00481	CbGeAlD
Almotriptan—MAOA—pituitary gland—brain cancer	0.000786	0.00479	CbGeAlD
Almotriptan—Convulsion—Procarbazine—brain cancer	0.000782	0.00451	CcSEcCtD
Almotriptan—Hypertension—Procarbazine—brain cancer	0.000779	0.00449	CcSEcCtD
Almotriptan—Arthralgia—Procarbazine—brain cancer	0.000768	0.00443	CcSEcCtD
Almotriptan—Myalgia—Procarbazine—brain cancer	0.000768	0.00443	CcSEcCtD
Almotriptan—Anxiety—Procarbazine—brain cancer	0.000766	0.00441	CcSEcCtD
Almotriptan—Sweating increased—Temozolomide—brain cancer	0.000763	0.0044	CcSEcCtD
Almotriptan—MAOA—medulla oblongata—brain cancer	0.000758	0.00462	CbGeAlD
Almotriptan—Bronchitis—Temozolomide—brain cancer	0.000753	0.00434	CcSEcCtD
Almotriptan—Dry mouth—Procarbazine—brain cancer	0.000751	0.00433	CcSEcCtD
Almotriptan—HTR1B—central nervous system—brain cancer	0.000744	0.00453	CbGeAlD
Almotriptan—Confusional state—Procarbazine—brain cancer	0.000743	0.00428	CcSEcCtD
Almotriptan—Vomiting—Lomustine—brain cancer	0.000738	0.00425	CcSEcCtD
Almotriptan—Hyperglycaemia—Carmustine—brain cancer	0.000731	0.00421	CcSEcCtD
Almotriptan—Shock—Procarbazine—brain cancer	0.000725	0.00418	CcSEcCtD
Almotriptan—CYP2E1—telencephalon—brain cancer	0.000724	0.00441	CbGeAlD
Almotriptan—HTR1D—central nervous system—brain cancer	0.00072	0.00439	CbGeAlD
Almotriptan—Chills—Hydroxyurea—brain cancer	0.00072	0.00415	CcSEcCtD
Almotriptan—Tachycardia—Procarbazine—brain cancer	0.000719	0.00414	CcSEcCtD
Almotriptan—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000716	0.00904	CbGpPWpGaD
Almotriptan—Photosensitivity reaction—Temozolomide—brain cancer	0.000715	0.00412	CcSEcCtD
Almotriptan—Hyperhidrosis—Procarbazine—brain cancer	0.000712	0.0041	CcSEcCtD
Almotriptan—Neuropathy peripheral—Carmustine—brain cancer	0.000708	0.00408	CcSEcCtD
Almotriptan—Hyperglycaemia—Temozolomide—brain cancer	0.000706	0.00407	CcSEcCtD
Almotriptan—CYP2C8—pituitary gland—brain cancer	0.000701	0.00427	CbGeAlD
Almotriptan—Erythema—Hydroxyurea—brain cancer	0.000698	0.00403	CcSEcCtD
Almotriptan—MAOA—midbrain—brain cancer	0.000693	0.00422	CbGeAlD
Almotriptan—Nausea—Lomustine—brain cancer	0.000689	0.00397	CcSEcCtD
Almotriptan—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000689	0.00869	CbGpPWpGaD
Almotriptan—Neuropathy peripheral—Temozolomide—brain cancer	0.000684	0.00394	CcSEcCtD
Almotriptan—MAOA—spinal cord—brain cancer	0.000676	0.00412	CbGeAlD
Almotriptan—Musculoskeletal discomfort—Procarbazine—brain cancer	0.000671	0.00387	CcSEcCtD
Almotriptan—Insomnia—Procarbazine—brain cancer	0.000666	0.00384	CcSEcCtD
Almotriptan—Paraesthesia—Procarbazine—brain cancer	0.000661	0.00381	CcSEcCtD
Almotriptan—Sinusitis—Temozolomide—brain cancer	0.000655	0.00378	CcSEcCtD
Almotriptan—Somnolence—Procarbazine—brain cancer	0.000655	0.00377	CcSEcCtD
Almotriptan—MAOA—Oxidative Stress—SOD2—brain cancer	0.000652	0.00823	CbGpPWpGaD
Almotriptan—Ill-defined disorder—Hydroxyurea—brain cancer	0.000648	0.00373	CcSEcCtD
Almotriptan—CYP2D6—brainstem—brain cancer	0.000646	0.00394	CbGeAlD
Almotriptan—Hypoaesthesia—Carmustine—brain cancer	0.000645	0.00372	CcSEcCtD
Almotriptan—CYP2C8—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000641	0.00809	CbGpPWpGaD
Almotriptan—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000641	0.00809	CbGpPWpGaD
Almotriptan—Fatigue—Procarbazine—brain cancer	0.000635	0.00366	CcSEcCtD
Almotriptan—CYP2E1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000632	0.00798	CbGpPWpGaD
Almotriptan—Malaise—Hydroxyurea—brain cancer	0.00063	0.00363	CcSEcCtD
Almotriptan—Pain—Procarbazine—brain cancer	0.00063	0.00363	CcSEcCtD
Almotriptan—Visual impairment—Carmustine—brain cancer	0.000625	0.0036	CcSEcCtD
Almotriptan—Hypoaesthesia—Temozolomide—brain cancer	0.000624	0.00359	CcSEcCtD
Almotriptan—Pharyngitis—Temozolomide—brain cancer	0.000622	0.00359	CcSEcCtD
Almotriptan—CYP2C19—endocrine gland—brain cancer	0.000622	0.00379	CbGeAlD
Almotriptan—Sweating increased—Etoposide—brain cancer	0.00061	0.00352	CcSEcCtD
Almotriptan—MAOA—endocrine gland—brain cancer	0.000609	0.00371	CbGeAlD
Almotriptan—Feeling abnormal—Procarbazine—brain cancer	0.000607	0.0035	CcSEcCtD
Almotriptan—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000607	0.00766	CbGpPWpGaD
Almotriptan—Eye disorder—Carmustine—brain cancer	0.000606	0.00349	CcSEcCtD
Almotriptan—Convulsion—Hydroxyurea—brain cancer	0.000605	0.00349	CcSEcCtD
Almotriptan—Visual impairment—Temozolomide—brain cancer	0.000604	0.00348	CcSEcCtD
Almotriptan—Gastrointestinal pain—Procarbazine—brain cancer	0.000602	0.00347	CcSEcCtD
Almotriptan—MAOA—head—brain cancer	0.000601	0.00366	CbGeAlD
Almotriptan—HTR1B—brain—brain cancer	0.000591	0.0036	CbGeAlD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—brain cancer	0.000591	0.0034	CcSEcCtD
Almotriptan—Discomfort—Hydroxyurea—brain cancer	0.000588	0.00339	CcSEcCtD
Almotriptan—Eye disorder—Temozolomide—brain cancer	0.000586	0.00338	CcSEcCtD
Almotriptan—Tinnitus—Temozolomide—brain cancer	0.000584	0.00337	CcSEcCtD
Almotriptan—Abdominal pain—Procarbazine—brain cancer	0.000582	0.00336	CcSEcCtD
Almotriptan—Body temperature increased—Procarbazine—brain cancer	0.000582	0.00336	CcSEcCtD
Almotriptan—Cardiac disorder—Temozolomide—brain cancer	0.000582	0.00335	CcSEcCtD
Almotriptan—CYP2D6—telencephalon—brain cancer	0.000574	0.00349	CbGeAlD
Almotriptan—CYP2C19—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000572	0.00722	CbGpPWpGaD
Almotriptan—HTR1D—brain—brain cancer	0.000572	0.00349	CbGeAlD
Almotriptan—CYP2E1—medulla oblongata—brain cancer	0.000569	0.00347	CbGeAlD
Almotriptan—Mental disorder—Carmustine—brain cancer	0.000568	0.00327	CcSEcCtD
Almotriptan—Immune system disorder—Temozolomide—brain cancer	0.000566	0.00326	CcSEcCtD
Almotriptan—Erythema—Carmustine—brain cancer	0.000565	0.00325	CcSEcCtD
Almotriptan—Chills—Temozolomide—brain cancer	0.000562	0.00324	CcSEcCtD
Almotriptan—Nervous system disorder—Hydroxyurea—brain cancer	0.000559	0.00322	CcSEcCtD
Almotriptan—CYP2C8—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000554	0.00699	CbGpPWpGaD
Almotriptan—Skin disorder—Hydroxyurea—brain cancer	0.000554	0.00319	CcSEcCtD
Almotriptan—Acute coronary syndrome—Etoposide—brain cancer	0.000551	0.00317	CcSEcCtD
Almotriptan—Mental disorder—Temozolomide—brain cancer	0.000549	0.00316	CcSEcCtD
Almotriptan—MAOA—central nervous system—brain cancer	0.000549	0.00334	CbGeAlD
Almotriptan—Myocardial infarction—Etoposide—brain cancer	0.000548	0.00316	CcSEcCtD
Almotriptan—Neuropathy peripheral—Etoposide—brain cancer	0.000548	0.00316	CcSEcCtD
Almotriptan—CYP2C8—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000547	0.0069	CbGpPWpGaD
Almotriptan—Back pain—Carmustine—brain cancer	0.000546	0.00315	CcSEcCtD
Almotriptan—Erythema—Temozolomide—brain cancer	0.000546	0.00314	CcSEcCtD
Almotriptan—CYP2C8—endocrine gland—brain cancer	0.000543	0.00331	CbGeAlD
Almotriptan—Hypersensitivity—Procarbazine—brain cancer	0.000543	0.00313	CcSEcCtD
Almotriptan—MAOA—cerebellum—brain cancer	0.000536	0.00327	CbGeAlD
Almotriptan—Dysgeusia—Temozolomide—brain cancer	0.000534	0.00308	CcSEcCtD
Almotriptan—Vision blurred—Carmustine—brain cancer	0.000532	0.00307	CcSEcCtD
Almotriptan—Tremor—Carmustine—brain cancer	0.000529	0.00305	CcSEcCtD
Almotriptan—MAOA—SIDS Susceptibility Pathways—HES5—brain cancer	0.000528	0.00667	CbGpPWpGaD
Almotriptan—Asthenia—Procarbazine—brain cancer	0.000528	0.00305	CcSEcCtD
Almotriptan—Back pain—Temozolomide—brain cancer	0.000528	0.00304	CcSEcCtD
Almotriptan—Pruritus—Procarbazine—brain cancer	0.000521	0.003	CcSEcCtD
Almotriptan—CYP2E1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00052	0.00656	CbGpPWpGaD
Almotriptan—Agitation—Carmustine—brain cancer	0.000519	0.00299	CcSEcCtD
Almotriptan—Vision blurred—Temozolomide—brain cancer	0.000514	0.00296	CcSEcCtD
Almotriptan—Tremor—Temozolomide—brain cancer	0.000511	0.00295	CcSEcCtD
Almotriptan—Dyspnoea—Hydroxyurea—brain cancer	0.000508	0.00293	CcSEcCtD
Almotriptan—CYP1A2—endocrine gland—brain cancer	0.000508	0.00309	CbGeAlD
Almotriptan—CYP2E1—spinal cord—brain cancer	0.000508	0.00309	CbGeAlD
Almotriptan—Somnolence—Hydroxyurea—brain cancer	0.000507	0.00292	CcSEcCtD
Almotriptan—Ill-defined disorder—Temozolomide—brain cancer	0.000506	0.00292	CcSEcCtD
Almotriptan—Diarrhoea—Procarbazine—brain cancer	0.000504	0.0029	CcSEcCtD
Almotriptan—Dyspepsia—Hydroxyurea—brain cancer	0.000502	0.00289	CcSEcCtD
Almotriptan—Agitation—Temozolomide—brain cancer	0.000501	0.00289	CcSEcCtD
Almotriptan—Hypoaesthesia—Etoposide—brain cancer	0.000499	0.00288	CcSEcCtD
Almotriptan—Angioedema—Temozolomide—brain cancer	0.000499	0.00287	CcSEcCtD
Almotriptan—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000494	0.00624	CbGpPWpGaD
Almotriptan—Gastrointestinal disorder—Hydroxyurea—brain cancer	0.000492	0.00284	CcSEcCtD
Almotriptan—Malaise—Temozolomide—brain cancer	0.000492	0.00284	CcSEcCtD
Almotriptan—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000492	0.00621	CbGpPWpGaD
Almotriptan—Fatigue—Hydroxyurea—brain cancer	0.000491	0.00283	CcSEcCtD
Almotriptan—Vertigo—Temozolomide—brain cancer	0.00049	0.00283	CcSEcCtD
Almotriptan—Convulsion—Carmustine—brain cancer	0.000489	0.00282	CcSEcCtD
Almotriptan—CYP2C19—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000488	0.00616	CbGpPWpGaD
Almotriptan—Hypertension—Carmustine—brain cancer	0.000487	0.00281	CcSEcCtD
Almotriptan—Pain—Hydroxyurea—brain cancer	0.000487	0.00281	CcSEcCtD
Almotriptan—Dizziness—Procarbazine—brain cancer	0.000487	0.00281	CcSEcCtD
Almotriptan—Palpitations—Temozolomide—brain cancer	0.000482	0.00278	CcSEcCtD
Almotriptan—Myalgia—Carmustine—brain cancer	0.000481	0.00277	CcSEcCtD
Almotriptan—Chest pain—Carmustine—brain cancer	0.000481	0.00277	CcSEcCtD
Almotriptan—Anxiety—Carmustine—brain cancer	0.000479	0.00276	CcSEcCtD
Almotriptan—Convulsion—Temozolomide—brain cancer	0.000473	0.00272	CcSEcCtD
Almotriptan—Hypertension—Temozolomide—brain cancer	0.000471	0.00271	CcSEcCtD
Almotriptan—FMO3—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000471	0.00594	CbGpPWpGaD
Almotriptan—Feeling abnormal—Hydroxyurea—brain cancer	0.00047	0.00271	CcSEcCtD
Almotriptan—Eye disorder—Etoposide—brain cancer	0.000469	0.0027	CcSEcCtD
Almotriptan—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000468	0.00591	CbGpPWpGaD
Almotriptan—Vomiting—Procarbazine—brain cancer	0.000468	0.0027	CcSEcCtD
Almotriptan—Cardiac disorder—Etoposide—brain cancer	0.000465	0.00268	CcSEcCtD
Almotriptan—Confusional state—Carmustine—brain cancer	0.000465	0.00268	CcSEcCtD
Almotriptan—Myalgia—Temozolomide—brain cancer	0.000465	0.00268	CcSEcCtD
Almotriptan—Arthralgia—Temozolomide—brain cancer	0.000465	0.00268	CcSEcCtD
Almotriptan—Rash—Procarbazine—brain cancer	0.000464	0.00268	CcSEcCtD
Almotriptan—Dermatitis—Procarbazine—brain cancer	0.000464	0.00267	CcSEcCtD
Almotriptan—Anxiety—Temozolomide—brain cancer	0.000463	0.00267	CcSEcCtD
Almotriptan—Headache—Procarbazine—brain cancer	0.000461	0.00266	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—brain cancer	0.000461	0.00266	CcSEcCtD
Almotriptan—Discomfort—Temozolomide—brain cancer	0.000459	0.00265	CcSEcCtD
Almotriptan—CYP2E1—endocrine gland—brain cancer	0.000457	0.00278	CbGeAlD
Almotriptan—CYP2D6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000455	0.00574	CbGpPWpGaD
Almotriptan—Dry mouth—Temozolomide—brain cancer	0.000454	0.00262	CcSEcCtD
Almotriptan—Immune system disorder—Etoposide—brain cancer	0.000453	0.00261	CcSEcCtD
Almotriptan—CYP2E1—head—brain cancer	0.000451	0.00275	CbGeAlD
Almotriptan—Body temperature increased—Hydroxyurea—brain cancer	0.000451	0.0026	CcSEcCtD
Almotriptan—Chills—Etoposide—brain cancer	0.00045	0.00259	CcSEcCtD
Almotriptan—MAOA—Biological oxidations—CYP2C9—brain cancer	0.00045	0.00568	CbGpPWpGaD
Almotriptan—Tachycardia—Carmustine—brain cancer	0.00045	0.00259	CcSEcCtD
Almotriptan—CYP2C8—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000449	0.00567	CbGpPWpGaD
Almotriptan—Confusional state—Temozolomide—brain cancer	0.000449	0.00259	CcSEcCtD
Almotriptan—CYP2D6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000449	0.00566	CbGpPWpGaD
Almotriptan—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000446	0.00563	CbGpPWpGaD
Almotriptan—Anaphylactic shock—Temozolomide—brain cancer	0.000445	0.00257	CcSEcCtD
Almotriptan—Nausea—Procarbazine—brain cancer	0.000437	0.00252	CcSEcCtD
Almotriptan—Nervous system disorder—Temozolomide—brain cancer	0.000437	0.00252	CcSEcCtD
Almotriptan—MAOA—brain—brain cancer	0.000435	0.00265	CbGeAlD
Almotriptan—Skin disorder—Temozolomide—brain cancer	0.000433	0.00249	CcSEcCtD
Almotriptan—Hyperhidrosis—Temozolomide—brain cancer	0.00043	0.00248	CcSEcCtD
Almotriptan—Dysgeusia—Etoposide—brain cancer	0.000428	0.00246	CcSEcCtD
Almotriptan—Back pain—Etoposide—brain cancer	0.000422	0.00243	CcSEcCtD
Almotriptan—Hypersensitivity—Hydroxyurea—brain cancer	0.00042	0.00242	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Carmustine—brain cancer	0.00042	0.00242	CcSEcCtD
Almotriptan—Insomnia—Carmustine—brain cancer	0.000417	0.0024	CcSEcCtD
Almotriptan—Paraesthesia—Carmustine—brain cancer	0.000414	0.00238	CcSEcCtD
Almotriptan—CYP2E1—central nervous system—brain cancer	0.000412	0.00251	CbGeAlD
Almotriptan—Dyspnoea—Carmustine—brain cancer	0.000411	0.00237	CcSEcCtD
Almotriptan—Somnolence—Carmustine—brain cancer	0.00041	0.00236	CcSEcCtD
Almotriptan—Asthenia—Hydroxyurea—brain cancer	0.000409	0.00236	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000406	0.00234	CcSEcCtD
Almotriptan—Ill-defined disorder—Etoposide—brain cancer	0.000405	0.00233	CcSEcCtD
Almotriptan—Insomnia—Temozolomide—brain cancer	0.000403	0.00232	CcSEcCtD
Almotriptan—CYP2E1—cerebellum—brain cancer	0.000402	0.00245	CbGeAlD
Almotriptan—CYP2C19—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000401	0.00506	CbGpPWpGaD
Almotriptan—Paraesthesia—Temozolomide—brain cancer	0.0004	0.0023	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Carmustine—brain cancer	0.000398	0.00229	CcSEcCtD
Almotriptan—Dyspnoea—Temozolomide—brain cancer	0.000397	0.00229	CcSEcCtD
Almotriptan—Somnolence—Temozolomide—brain cancer	0.000396	0.00228	CcSEcCtD
Almotriptan—Pain—Carmustine—brain cancer	0.000394	0.00227	CcSEcCtD
Almotriptan—Malaise—Etoposide—brain cancer	0.000394	0.00227	CcSEcCtD
Almotriptan—Vertigo—Etoposide—brain cancer	0.000392	0.00226	CcSEcCtD
Almotriptan—Dyspepsia—Temozolomide—brain cancer	0.000392	0.00226	CcSEcCtD
Almotriptan—Diarrhoea—Hydroxyurea—brain cancer	0.00039	0.00225	CcSEcCtD
Almotriptan—CYP2C8—brain—brain cancer	0.000388	0.00237	CbGeAlD
Almotriptan—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000385	0.00486	CbGpPWpGaD
Almotriptan—Gastrointestinal disorder—Temozolomide—brain cancer	0.000384	0.00222	CcSEcCtD
Almotriptan—Fatigue—Temozolomide—brain cancer	0.000384	0.00221	CcSEcCtD
Almotriptan—Loss of consciousness—Etoposide—brain cancer	0.000384	0.00221	CcSEcCtD
Almotriptan—Pain—Temozolomide—brain cancer	0.000381	0.00219	CcSEcCtD
Almotriptan—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00038	0.0048	CbGpPWpGaD
Almotriptan—Feeling abnormal—Carmustine—brain cancer	0.00038	0.00219	CcSEcCtD
Almotriptan—Convulsion—Etoposide—brain cancer	0.000378	0.00218	CcSEcCtD
Almotriptan—Hypertension—Etoposide—brain cancer	0.000377	0.00217	CcSEcCtD
Almotriptan—Dizziness—Hydroxyurea—brain cancer	0.000377	0.00217	CcSEcCtD
Almotriptan—Gastrointestinal pain—Carmustine—brain cancer	0.000377	0.00217	CcSEcCtD
Almotriptan—Chest pain—Etoposide—brain cancer	0.000372	0.00214	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Etoposide—brain cancer	0.000369	0.00213	CcSEcCtD
Almotriptan—CYP2D6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000369	0.00465	CbGpPWpGaD
Almotriptan—CYP3A4—endocrine gland—brain cancer	0.000368	0.00224	CbGeAlD
Almotriptan—Discomfort—Etoposide—brain cancer	0.000367	0.00212	CcSEcCtD
Almotriptan—Feeling abnormal—Temozolomide—brain cancer	0.000367	0.00211	CcSEcCtD
Almotriptan—FMO3—SIDS Susceptibility Pathways—HES1—brain cancer	0.000365	0.00461	CbGpPWpGaD
Almotriptan—Abdominal pain—Carmustine—brain cancer	0.000364	0.0021	CcSEcCtD
Almotriptan—Body temperature increased—Carmustine—brain cancer	0.000364	0.0021	CcSEcCtD
Almotriptan—Gastrointestinal pain—Temozolomide—brain cancer	0.000364	0.0021	CcSEcCtD
Almotriptan—Vomiting—Hydroxyurea—brain cancer	0.000362	0.00209	CcSEcCtD
Almotriptan—CYP2D6—endocrine gland—brain cancer	0.000362	0.0022	CbGeAlD
Almotriptan—Rash—Hydroxyurea—brain cancer	0.000359	0.00207	CcSEcCtD
Almotriptan—Confusional state—Etoposide—brain cancer	0.000359	0.00207	CcSEcCtD
Almotriptan—Dermatitis—Hydroxyurea—brain cancer	0.000359	0.00207	CcSEcCtD
Almotriptan—CYP2D6—head—brain cancer	0.000357	0.00218	CbGeAlD
Almotriptan—Headache—Hydroxyurea—brain cancer	0.000357	0.00206	CcSEcCtD
Almotriptan—Anaphylactic shock—Etoposide—brain cancer	0.000356	0.00205	CcSEcCtD
Almotriptan—Body temperature increased—Temozolomide—brain cancer	0.000352	0.00203	CcSEcCtD
Almotriptan—Abdominal pain—Temozolomide—brain cancer	0.000352	0.00203	CcSEcCtD
Almotriptan—Tachycardia—Etoposide—brain cancer	0.000348	0.002	CcSEcCtD
Almotriptan—Skin disorder—Etoposide—brain cancer	0.000346	0.00199	CcSEcCtD
Almotriptan—Hyperhidrosis—Etoposide—brain cancer	0.000344	0.00199	CcSEcCtD
Almotriptan—Hypersensitivity—Carmustine—brain cancer	0.00034	0.00196	CcSEcCtD
Almotriptan—Nausea—Hydroxyurea—brain cancer	0.000339	0.00195	CcSEcCtD
Almotriptan—CYP3A4—central nervous system—brain cancer	0.000331	0.00202	CbGeAlD
Almotriptan—Asthenia—Carmustine—brain cancer	0.000331	0.00191	CcSEcCtD
Almotriptan—Hypersensitivity—Temozolomide—brain cancer	0.000328	0.00189	CcSEcCtD
Almotriptan—CYP2E1—brain—brain cancer	0.000327	0.00199	CbGeAlD
Almotriptan—CYP2D6—central nervous system—brain cancer	0.000326	0.00199	CbGeAlD
Almotriptan—Paraesthesia—Etoposide—brain cancer	0.00032	0.00184	CcSEcCtD
Almotriptan—Asthenia—Temozolomide—brain cancer	0.00032	0.00184	CcSEcCtD
Almotriptan—CYP2D6—cerebellum—brain cancer	0.000319	0.00194	CbGeAlD
Almotriptan—Dyspnoea—Etoposide—brain cancer	0.000318	0.00183	CcSEcCtD
Almotriptan—Somnolence—Etoposide—brain cancer	0.000317	0.00183	CcSEcCtD
Almotriptan—Diarrhoea—Carmustine—brain cancer	0.000315	0.00182	CcSEcCtD
Almotriptan—Pruritus—Temozolomide—brain cancer	0.000315	0.00182	CcSEcCtD
Almotriptan—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000312	0.00394	CbGpPWpGaD
Almotriptan—Gastrointestinal disorder—Etoposide—brain cancer	0.000308	0.00177	CcSEcCtD
Almotriptan—Fatigue—Etoposide—brain cancer	0.000307	0.00177	CcSEcCtD
Almotriptan—Dizziness—Carmustine—brain cancer	0.000305	0.00176	CcSEcCtD
Almotriptan—Pain—Etoposide—brain cancer	0.000305	0.00176	CcSEcCtD
Almotriptan—Diarrhoea—Temozolomide—brain cancer	0.000305	0.00176	CcSEcCtD
Almotriptan—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000297	0.00375	CbGpPWpGaD
Almotriptan—Dizziness—Temozolomide—brain cancer	0.000294	0.0017	CcSEcCtD
Almotriptan—Feeling abnormal—Etoposide—brain cancer	0.000294	0.00169	CcSEcCtD
Almotriptan—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000293	0.0037	CbGpPWpGaD
Almotriptan—Vomiting—Carmustine—brain cancer	0.000293	0.00169	CcSEcCtD
Almotriptan—Gastrointestinal pain—Etoposide—brain cancer	0.000291	0.00168	CcSEcCtD
Almotriptan—Rash—Carmustine—brain cancer	0.000291	0.00167	CcSEcCtD
Almotriptan—Dermatitis—Carmustine—brain cancer	0.00029	0.00167	CcSEcCtD
Almotriptan—Headache—Carmustine—brain cancer	0.000289	0.00166	CcSEcCtD
Almotriptan—Vomiting—Temozolomide—brain cancer	0.000283	0.00163	CcSEcCtD
Almotriptan—Abdominal pain—Etoposide—brain cancer	0.000282	0.00162	CcSEcCtD
Almotriptan—Body temperature increased—Etoposide—brain cancer	0.000282	0.00162	CcSEcCtD
Almotriptan—Rash—Temozolomide—brain cancer	0.000281	0.00162	CcSEcCtD
Almotriptan—Dermatitis—Temozolomide—brain cancer	0.000281	0.00162	CcSEcCtD
Almotriptan—Headache—Temozolomide—brain cancer	0.000279	0.00161	CcSEcCtD
Almotriptan—CYP2E1—Biological oxidations—CYP2C9—brain cancer	0.000276	0.00348	CbGpPWpGaD
Almotriptan—Nausea—Carmustine—brain cancer	0.000274	0.00158	CcSEcCtD
Almotriptan—CYP2E1—Metapathway biotransformation—CYP2C9—brain cancer	0.000272	0.00344	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—PTCH2—brain cancer	0.000271	0.00342	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—PTCH2—brain cancer	0.000266	0.00335	CbGpPWpGaD
Almotriptan—Nausea—Temozolomide—brain cancer	0.000265	0.00152	CcSEcCtD
Almotriptan—Hypersensitivity—Etoposide—brain cancer	0.000263	0.00151	CcSEcCtD
Almotriptan—CYP2D6—brain—brain cancer	0.000259	0.00158	CbGeAlD
Almotriptan—Asthenia—Etoposide—brain cancer	0.000256	0.00147	CcSEcCtD
Almotriptan—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000253	0.00319	CbGpPWpGaD
Almotriptan—Pruritus—Etoposide—brain cancer	0.000252	0.00145	CcSEcCtD
Almotriptan—Diarrhoea—Etoposide—brain cancer	0.000244	0.00141	CcSEcCtD
Almotriptan—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000241	0.00304	CbGpPWpGaD
Almotriptan—CYP2C8—Biological oxidations—CYP2C9—brain cancer	0.000239	0.00301	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—OR14C36—brain cancer	0.000238	0.003	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—OR4C12—brain cancer	0.000238	0.003	CbGpPWpGaD
Almotriptan—Dizziness—Etoposide—brain cancer	0.000236	0.00136	CcSEcCtD
Almotriptan—CYP2C8—Metapathway biotransformation—CYP2C9—brain cancer	0.000235	0.00297	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—OR4C12—brain cancer	0.000233	0.00294	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—OR14C36—brain cancer	0.000233	0.00294	CbGpPWpGaD
Almotriptan—Vomiting—Etoposide—brain cancer	0.000227	0.00131	CcSEcCtD
Almotriptan—MAOA—SIDS Susceptibility Pathways—ESR2—brain cancer	0.000225	0.00284	CbGpPWpGaD
Almotriptan—Rash—Etoposide—brain cancer	0.000225	0.00129	CcSEcCtD
Almotriptan—Dermatitis—Etoposide—brain cancer	0.000224	0.00129	CcSEcCtD
Almotriptan—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000224	0.00283	CbGpPWpGaD
Almotriptan—Headache—Etoposide—brain cancer	0.000223	0.00129	CcSEcCtD
Almotriptan—HTR1D—Signaling by GPCR—OR4C12—brain cancer	0.000216	0.00273	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—OR14C36—brain cancer	0.000216	0.00273	CbGpPWpGaD
Almotriptan—CYP2C19—Biological oxidations—CYP2C9—brain cancer	0.000213	0.00269	CbGpPWpGaD
Almotriptan—Nausea—Etoposide—brain cancer	0.000212	0.00122	CcSEcCtD
Almotriptan—HTR1B—Signaling by GPCR—OR4C12—brain cancer	0.000212	0.00267	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—OR14C36—brain cancer	0.000212	0.00267	CbGpPWpGaD
Almotriptan—CYP2C19—Metapathway biotransformation—CYP2C9—brain cancer	0.00021	0.00265	CbGpPWpGaD
Almotriptan—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000206	0.0026	CbGpPWpGaD
Almotriptan—CYP2D6—Biological oxidations—CYP2C9—brain cancer	0.000196	0.00247	CbGpPWpGaD
Almotriptan—CYP2D6—Metapathway biotransformation—CYP2C9—brain cancer	0.000193	0.00244	CbGpPWpGaD
Almotriptan—FMO3—SIDS Susceptibility Pathways—CTNNB1—brain cancer	0.000183	0.00231	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—HES1—brain cancer	0.000175	0.0022	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000171	0.00216	CbGpPWpGaD
Almotriptan—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000166	0.00209	CbGpPWpGaD
Almotriptan—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000164	0.00207	CbGpPWpGaD
Almotriptan—FMO3—SIDS Susceptibility Pathways—VEGFA—brain cancer	0.000161	0.00204	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—CYP2C9—brain cancer	0.000161	0.00203	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—SHH—brain cancer	0.00014	0.00176	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PTCH2—brain cancer	0.000139	0.00176	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—BSG—brain cancer	0.000137	0.00173	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—SHH—brain cancer	0.000137	0.00173	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PTCH2—brain cancer	0.000136	0.00172	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—SMO—brain cancer	0.000132	0.00167	CbGpPWpGaD
Almotriptan—HTR1D—GPCR ligand binding—PTCH1—brain cancer	0.000132	0.00167	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—SMO—brain cancer	0.00013	0.00164	CbGpPWpGaD
Almotriptan—HTR1B—GPCR ligand binding—PTCH1—brain cancer	0.00013	0.00164	CbGpPWpGaD
Almotriptan—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000128	0.00162	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—OR14C36—brain cancer	0.000128	0.00161	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—OR4C12—brain cancer	0.000128	0.00161	CbGpPWpGaD
Almotriptan—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000126	0.00159	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—OR4C12—brain cancer	0.000125	0.00158	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—OR14C36—brain cancer	0.000125	0.00158	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—ABR—brain cancer	0.00012	0.00152	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—ABR—brain cancer	0.000118	0.00149	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—IDH1—brain cancer	0.000118	0.00149	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—ABR—brain cancer	0.000109	0.00138	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—DTX2—brain cancer	0.000109	0.00137	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—ABR—brain cancer	0.000107	0.00135	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—DTX2—brain cancer	0.000106	0.00134	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	9.87e-05	0.00125	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—ENO2—brain cancer	9.3e-05	0.00117	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	9.16e-05	0.00116	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	8.89e-05	0.00112	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—CTNNB1—brain cancer	8.76e-05	0.00111	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PTCH2—brain cancer	8.22e-05	0.00104	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	8.18e-05	0.00103	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PTCH2—brain cancer	8.05e-05	0.00102	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HES5—brain cancer	7.97e-05	0.00101	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HES5—brain cancer	7.8e-05	0.000984	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—STRADA—brain cancer	7.73e-05	0.000976	CbGpPWpGaD
Almotriptan—MAOA—SIDS Susceptibility Pathways—VEGFA—brain cancer	7.71e-05	0.000973	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—CYP2C9—brain cancer	7.69e-05	0.000971	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—TRPC6—brain cancer	7.62e-05	0.000961	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—STRADA—brain cancer	7.57e-05	0.000956	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	7.56e-05	0.000954	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—TRPC6—brain cancer	7.46e-05	0.000941	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—SHH—brain cancer	7.17e-05	0.000905	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—SHH—brain cancer	7.02e-05	0.000886	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	6.95e-05	0.000877	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—TRPC6—brain cancer	6.92e-05	0.000873	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	6.8e-05	0.000858	CbGpPWpGaD
Almotriptan—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	6.8e-05	0.000858	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—SMO—brain cancer	6.8e-05	0.000858	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PTCH1—brain cancer	6.8e-05	0.000858	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—TRPC6—brain cancer	6.77e-05	0.000855	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—IDH1—brain cancer	6.7e-05	0.000845	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—SMO—brain cancer	6.66e-05	0.00084	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PTCH1—brain cancer	6.66e-05	0.00084	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—BSG—brain cancer	6.54e-05	0.000826	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ABR—brain cancer	6.45e-05	0.000815	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	6.37e-05	0.000804	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ABR—brain cancer	6.32e-05	0.000798	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—GLI2—brain cancer	6.23e-05	0.000787	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—GLI2—brain cancer	6.1e-05	0.00077	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.98e-05	0.000755	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—GLI1—brain cancer	5.86e-05	0.00074	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—GLI1—brain cancer	5.74e-05	0.000724	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—VAV1—brain cancer	5.71e-05	0.00072	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—IDH1—brain cancer	5.62e-05	0.00071	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—VAV1—brain cancer	5.59e-05	0.000705	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SUFU—brain cancer	5.56e-05	0.000701	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SUFU—brain cancer	5.44e-05	0.000687	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—GFAP—brain cancer	5.36e-05	0.000677	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—GFAP—brain cancer	5.25e-05	0.000662	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—VAV1—brain cancer	5.18e-05	0.000654	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HEY1—brain cancer	5.08e-05	0.000641	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—VAV1—brain cancer	5.07e-05	0.00064	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—DLL1—brain cancer	4.98e-05	0.000629	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HEY1—brain cancer	4.98e-05	0.000628	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—DLL1—brain cancer	4.88e-05	0.000616	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—CYP2C9—brain cancer	4.72e-05	0.000596	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	4.66e-05	0.000588	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—ENO2—brain cancer	4.45e-05	0.000561	CbGpPWpGaD
Almotriptan—FMO3—Metabolism—PIK3CG—brain cancer	4.27e-05	0.000539	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SHH—brain cancer	4.24e-05	0.000535	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SHH—brain cancer	4.15e-05	0.000524	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TRPC6—brain cancer	4.09e-05	0.000516	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—CYP2C9—brain cancer	4.08e-05	0.000515	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SMO—brain cancer	4.02e-05	0.000507	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PTCH1—brain cancer	4.02e-05	0.000507	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—BSG—brain cancer	4.01e-05	0.000507	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TRPC6—brain cancer	4e-05	0.000505	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SMO—brain cancer	3.93e-05	0.000496	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PTCH1—brain cancer	3.93e-05	0.000496	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—CYP2C9—brain cancer	3.64e-05	0.00046	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—PIK3CG—brain cancer	3.62e-05	0.000457	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—PIK3CG—brain cancer	3.55e-05	0.000448	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—BSG—brain cancer	3.47e-05	0.000438	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—IDH1—brain cancer	3.45e-05	0.000436	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—CYP2C9—brain cancer	3.35e-05	0.000423	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—PIK3CG—brain cancer	3.29e-05	0.000415	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—PIK3CG—brain cancer	3.22e-05	0.000407	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—NOTCH2—brain cancer	3.21e-05	0.000405	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—NOTCH2—brain cancer	3.14e-05	0.000397	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—BSG—brain cancer	3.1e-05	0.000391	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—VAV1—brain cancer	3.06e-05	0.000386	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—VAV1—brain cancer	3e-05	0.000378	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—IDH1—brain cancer	2.98e-05	0.000376	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—BSG—brain cancer	2.85e-05	0.000359	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—CYP2C9—brain cancer	2.84e-05	0.000358	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—ENO2—brain cancer	2.73e-05	0.000344	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—IDH1—brain cancer	2.66e-05	0.000336	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—HES1—brain cancer	2.63e-05	0.000332	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—HES1—brain cancer	2.58e-05	0.000325	CbGpPWpGaD
Almotriptan—HTR1D—GPCR downstream signaling—IL2—brain cancer	2.55e-05	0.000322	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PDGFRA—brain cancer	2.51e-05	0.000316	CbGpPWpGaD
Almotriptan—HTR1B—GPCR downstream signaling—IL2—brain cancer	2.5e-05	0.000315	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PDGFRA—brain cancer	2.45e-05	0.00031	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—IDH1—brain cancer	2.45e-05	0.000309	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—SPP1—brain cancer	2.43e-05	0.000307	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.43e-05	0.000307	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—BSG—brain cancer	2.41e-05	0.000304	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—SPP1—brain cancer	2.38e-05	0.000301	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—ENO2—brain cancer	2.36e-05	0.000298	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—IL2—brain cancer	2.32e-05	0.000292	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—IL2—brain cancer	2.27e-05	0.000286	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IRS2—brain cancer	2.2e-05	0.000278	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—CYP2C9—brain cancer	2.19e-05	0.000276	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	2.17e-05	0.000274	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IRS2—brain cancer	2.15e-05	0.000272	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—ENO2—brain cancer	2.1e-05	0.000266	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—IDH1—brain cancer	2.07e-05	0.000262	CbGpPWpGaD
Almotriptan—MAOA—Metabolism—PIK3CG—brain cancer	2.04e-05	0.000257	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—APC—brain cancer	1.94e-05	0.000245	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—PIK3CG—brain cancer	1.94e-05	0.000245	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—ENO2—brain cancer	1.94e-05	0.000244	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—APC—brain cancer	1.9e-05	0.00024	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—PIK3CG—brain cancer	1.9e-05	0.00024	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—BSG—brain cancer	1.86e-05	0.000235	CbGpPWpGaD
Almotriptan—HTR1D—Signaling by GPCR—EGFR—brain cancer	1.77e-05	0.000224	CbGpPWpGaD
Almotriptan—HTR1B—Signaling by GPCR—EGFR—brain cancer	1.73e-05	0.000219	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.69e-05	0.000213	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—ENO2—brain cancer	1.64e-05	0.000207	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—IDH1—brain cancer	1.6e-05	0.000202	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—RELA—brain cancer	1.52e-05	0.000192	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—ERBB2—brain cancer	1.51e-05	0.00019	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—RELA—brain cancer	1.49e-05	0.000188	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—ERBB2—brain cancer	1.48e-05	0.000187	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—IL2—brain cancer	1.37e-05	0.000173	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—IL2—brain cancer	1.34e-05	0.000169	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CCND1—brain cancer	1.33e-05	0.000168	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—CTNNB1—brain cancer	1.32e-05	0.000167	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CCND1—brain cancer	1.31e-05	0.000165	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—CTNNB1—brain cancer	1.29e-05	0.000163	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—ENO2—brain cancer	1.27e-05	0.00016	CbGpPWpGaD
Almotriptan—CYP2E1—Metabolism—PIK3CG—brain cancer	1.25e-05	0.000158	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—VEGFA—brain cancer	1.16e-05	0.000147	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—STAT3—brain cancer	1.15e-05	0.000145	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—VEGFA—brain cancer	1.14e-05	0.000144	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—STAT3—brain cancer	1.13e-05	0.000142	CbGpPWpGaD
Almotriptan—CYP2C8—Metabolism—PIK3CG—brain cancer	1.08e-05	0.000137	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—MYC—brain cancer	1.07e-05	0.000135	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—MYC—brain cancer	1.05e-05	0.000132	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—EGFR—brain cancer	1.05e-05	0.000132	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—EGFR—brain cancer	1.02e-05	0.000129	CbGpPWpGaD
Almotriptan—CYP2C19—Metabolism—PIK3CG—brain cancer	9.65e-06	0.000122	CbGpPWpGaD
Almotriptan—CYP2D6—Metabolism—PIK3CG—brain cancer	8.88e-06	0.000112	CbGpPWpGaD
Almotriptan—HTR1D—Signaling Pathways—TP53—brain cancer	8.78e-06	0.000111	CbGpPWpGaD
Almotriptan—HTR1B—Signaling Pathways—TP53—brain cancer	8.6e-06	0.000109	CbGpPWpGaD
Almotriptan—CYP1A2—Metabolism—PIK3CG—brain cancer	7.52e-06	9.5e-05	CbGpPWpGaD
Almotriptan—CYP3A4—Metabolism—PIK3CG—brain cancer	5.81e-06	7.33e-05	CbGpPWpGaD
